40 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
, the Economic Department of the Tel Aviv District Court (the “Court”) approved the Company’s share repurchase program. The Court determined, in accordance
6-K
ENLV
Enlivex Therapeutics Ltd
22 Jan 24
Report of Foreign Private Issuer
8:00am
approval. On November 2, 2023, the Economic Department of the Tel Aviv District Court (the “Court”) approved the Company’s share repurchase program
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
.
On November 2, 2023, the Economic Department of the Tel Aviv District Court (the “Court”) approved the Company’s share repurchase program for up
6-K
ENLV
Enlivex Therapeutics Ltd
7 Nov 23
Report of Foreign Private Issuer
4:30pm
approval. On November 2, 2023, the Economic Department of the Tel Aviv District Court (the “Court”) approved the Company’s share repurchase program
6-K
ENLV
Enlivex Therapeutics Ltd
18 Sep 23
Report of Foreign Private Issuer
8:00am
repurchase program is subject to the approval of the Economic Department of the Tel Aviv District Court, and, on September 18, 2023, the Company made
6-K
EX-99.1
vhf0w 39u80wyw36y2z
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-10.1
btrmp 3iv
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.1
i7j7k0w
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
vygu1rejx4
6 Jul 22
Current report (foreign)
8:41am
6-K
EX-99.1
fyy8th6y
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-99.1
8o74019fgbsiqm79
1 Mar 21
Report of Foreign Private Issuer
7:58am
6-K
EX-1.1
szv63
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
a3j18g7brht50czql3x
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-99.1
33bz2rl8l4s9q
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
g41nfn2sh6ymmuf
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
vlhagh6 qtl41m
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm